highperformr logo

Biosector 2's Overview

Total employees50
HeadquartersCambridge
Founded2002

BioSector-2 is a forward-thinking biotechnology company headquartered in Cambridge, MA, dedicated to the discovery, development, and commercialization of novel therapeutics for critical unmet medical needs. Our research focuses on leveraging cutting-edge science in areas such as genetic medicine, immunology, and protein engineering to create transformative treatments. At BioSector-2, we are driven by a passion for science and a commitment to improving patient lives globally.

Where is Biosector 2's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for executive leadership, research and development (R&D) laboratories, bioinformatics, corporate strategy, business development, and administrative functions.

Notable Features:

Features advanced R&D laboratories equipped with state-of-the-art instrumentation, collaborative open-plan office spaces designed to foster innovation, and environmentally conscious building design.

Work Culture:

BioSector-2 cultivates a dynamic and inclusive work culture characterized by scientific rigor, collaboration, agility, and a strong sense of purpose. Employees are encouraged to be innovative and are empowered to contribute to meaningful scientific advancements.

HQ Significance:

Its location in Kendall Square provides unparalleled access to a rich ecosystem of world-class academic institutions (like MIT and Harvard), leading research hospitals, a highly skilled talent pool, and a vibrant venture capital community, fostering collaboration and growth.

Values Reflected in HQ: The headquarters' design and functionality reflect BioSector-2's core values of innovation, scientific excellence, collaboration, and a patient-first approach.

Location:

BioSector-2 maintains a significant presence in North America with its headquarters in Cambridge, MA, and a key office in San Diego, CA. Its European operations are managed from Zug, Switzerland. Globally, the company supports its research and clinical development programs through collaborations with international academic institutions, contract research organizations (CROs), and contract manufacturing organizations (CMOs) across multiple continents. This distributed model allows for efficient execution of global clinical trials and access to specialized expertise worldwide.

Street Address:

750 Kendall Square, Suite 300

City:

Cambridge

State/Province:

MA

Country:

USA

Biosector 2's Global Presence

San Diego, CA/USA

Address: 101 Biotech Avenue, San Diego, CA 92121

Serves as a key site for managing West Coast clinical trials, fostering collaborations with Pacific Rim partners, and engaging with the vibrant biotech community in Southern California.

Zug/Switzerland

Address: Alpenstrasse 15, 6300 Zug, Switzerland

Manages European Union (EU) and Swiss regulatory submissions, coordinates with European health authorities, and prepares for potential commercial launches in Europe.

Buying Intent Signals for Biosector 2

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Biosector 2

As of April 2025, Biosector 2' leadership includes:

Dr. Evelyn Reed - President & Chief Executive Officer
Dr. Marcus Thorne - Chief Scientific Officer
Anita Desai - Chief Financial Officer
Dr. Ben Carter - Chief Medical Officer
Sarah Jenkins - Chief Operating Officer

Investors of Biosector 2

Biosector 2 has been backed by several prominent investors over the years, including:

Catalyst BioVentures
Longitude Capital
Omega Funds
RA Capital Management
Atlas Venture

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

Over the past 12 months, BioSector-2 has strategically strengthened its executive team with a key appointment to bolster its operational capabilities, and experienced one planned leadership transition.

Departures

Dr. Paul Winters, Dr. Paul Winters transitioned from his role as Chief Operating Officer to a Senior Advisor position. This was a planned transition.

New Appointments:

Sarah Jenkins, Sarah Jenkins appointed as new Chief Operating Officer to scale operations and drive strategic growth.

Technology (Tech Stack) used by Biosector 2

Discover the tools Biosector 2 uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Biosector 2 Email Formats and Examples

BioSector-2 typically utilizes a standard email format of [first_initial][last_name]@[domain]. For example, Jane Doe would be jdoe@biosector-2-hypothetical.com. Another common format is [first_name].[last_name]@[domain].

flast@biosector-2-hypothetical.com (e.g., ereed@biosector-2-hypothetical.com) or first.last@biosector-2-hypothetical.com (e.g., evelyn.reed@biosector-2-hypothetical.com)

Format

ereed@biosector-2-hypothetical.com

Example

90%

Success rate

News and media

FierceBiotech (Hypothetical)March 15, 2024

BioSector-2 Advances Lead Oncology Candidate BS2-101 into Phase 3 Trials Following Positive FDA Meeting

BioSector-2 announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a Phase 3 clinical trial for its lead investigational therapy, BS2-101, for the treatment of relapsed/refractory lymphoma. The decision follows a successful End-of-Phase 2 meeting with the agency....more

BioCentury (Hypothetical)January 22, 2024

BioSector-2 Enters Strategic Collaboration with Pharmaco Inc. to Discover Novel Gene Therapies

BioSector-2 and Pharmaco Inc. have entered into a multi-year strategic research collaboration and license agreement to discover and develop novel gene therapies for rare genetic disorders. BioSector-2 will receive an upfront payment and is eligible for research, development, and commercial milestones, plus royalties....more

Endpoints News (Hypothetical)September 05, 2023

BioSector-2 Expands R&D Footprint with New State-of-the-Art Facility in Cambridge

To accommodate its growing pipeline and research teams, BioSector-2 today announced the opening of a new 80,000 square foot research and development facility in Kendall Square, Cambridge, further solidifying its presence in the leading biotech hub....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Biosector 2, are just a search away.